|
Market Closed -
Nasdaq
05:00:00 07/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 25.48 USD | +12.74% |
|
+15.45% | +44.44% |
| 11-07 | Zai Lab Q3 Performance Meets Expectations With Pivotal 2027 Ahead, UBS Says | MT |
| 11-06 | Zai Lab Q3 Loss Widens, Revenue Declines | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ZAI LAB LIMITED | Biopharmaceuticals | +12.74% | +15.45% | +44.44% | +10.06% | -71.21% | 3.16B |  |  | |
- Stock Market
- Stocks
- ZLAB Stock
- Charts Zai Lab Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
